ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2022

Elevated Serum Osteoprotegerin is Associated with Reduced Risks of Albuminuria and CKD Progression in Patients with Type 2 Diabetes.

Xiaoyang Lou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.